Analyst
LifeSci Advisors
Head of Investor Relations
Protalix BioTherapeutics, Inc. (PLX)Head of Investor Relations
Bionano Genomics, Inc. (BNGO)Head of Investor Relations
Standard Biotools Inc. (LAB)Board Member
Socket Mobile, Inc. (SCKT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
David Holmes is recorded as Analyst at LifeSci Advisors, Head of Investor Relations at Protalix BioTherapeutics, Inc. (PLX), Head of Investor Relations at Bionano Genomics, Inc. (BNGO), Head of Investor Relations at Standard Biotools Inc. (LAB) and Board Member at Socket Mobile, Inc. (SCKT). Socket Mobile, Inc. reported in an 8-K filed August 5, 2026 that David Holmes was appointed member of the Board, effective August 3, 2026. David Holmes has spoken on 11 earnings calls across 3 companies, most recently for Bionano Genomics, Inc. on May 14, 2025.
“On August 3, 2026, the Board of Directors (the "Board") of Socket Mobile, Inc. (the "Company") appointed David Holmes to serve as a member of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-08-03–present
LifeSci Advisors
Analyst
Source not stated
Proxy statement
Recorded roles and call appearances connecting this person to public companies.
Head of Investor Relations
Head of Investor Relations
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
